UBS initiated coverage of Incyte (INCY) with a Neutral rating and $77 price target The firm sees a balanced risk/reward amid the company’s diversification efforts beyond the core business.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INCY: